Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-10-20 Sale |
2021-10-20 7:14 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
10,083 | $58.67 | $591,527 | 779,218 (Direct) |
View |
| 2021-10-18 Sale |
2021-10-19 7:27 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
52,417 | $58.65 | $3,074,378 | 769,135 (Direct) |
View |
| 2021-10-13 Sale |
2021-10-13 8:24 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $55.97 | $559,675 | 251,807 (Direct) |
View |
| 2021-08-10 Sale |
2021-08-12 8:38 pm |
SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
1,000,000 | $70.25 | $70,250,000 | 4,832,413 (Indirect Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 7:34 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
62,500 | $76.56 | $4,785,189 | 821,552 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-14 4:28 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $80.88 | $808,777 | 261,807 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-06 4:42 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
15,959 | $85.01 | $1,356,675 | 6,028,307 (Indirect) |
View |
| 2021-07-01 Sale |
2021-07-01 6:30 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
32,000 | $85.35 | $2,731,088 | 301,541 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 9:01 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
6,502 | $85.17 | $553,775 | 6,044,266 (Indirect) |
View |
| 2021-06-23 Sale |
2021-06-25 7:11 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
56,634 | $85.19 | $4,824,541 | 6,050,768 (Indirect) |
View |
| 2021-06-10 Sale |
2021-06-14 5:58 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
30,852 | $85.09 | $2,625,197 | 6,107,402 (Indirect) |
View |
| 2021-06-07 Sale |
2021-06-09 6:26 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
48,053 | $85.36 | $4,101,908 | 6,138,254 (Indirect) |
View |
| 2021-04-27 Sale |
2021-04-28 8:18 pm |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
19,432 | $76.19 | $1,480,522 | 125,728 (Direct) |
View |
| 2021-04-19 Sale |
2021-04-20 6:51 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
62,500 | $68.02 | $4,251,106 | 884,052 (Direct) |
View |
| 2021-04-14 Sale |
2021-04-19 06:07 am |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
1,568 | $75.04 | $117,655 | 145,160 (Direct) |
View |
| 2021-04-13 Sale |
2021-04-13 8:21 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $68.07 | $680,723 | 271,807 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
842 | $56.06 | 21,456 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr Chief Financial Officer |
1,846 | $56.06 | 26,963 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
567 | $56.06 | 8,181 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,772 | $56.06 | 187,944 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
5,893 | $56.06 | 851,695 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
2,531 | $56.06 | 325,134 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:31 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
322,628 | $0 | 1,101,846 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:27 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
107,544 | $0 | 409,085 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:26 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr Chief Financial Officer |
77,431 | $0 | 87,431 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:25 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
91,412 | $0 | 258,923 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:25 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
53,772 | $0 | 60,772 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:24 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
53,772 | $0 | 63,008 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
64,526 | $0 | 92,026 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:23 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
53,772 | $0 | 66,272 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 4:22 pm |
N/A 2032-01-06 |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
23,661 | $0 | 26,661 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 251,807 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-13 8:24 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 251,807 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:15 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
2,320 | $43.1 | 81,916 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:15 pm |
N/A 2030-08-03 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
2,320 | $0 | 81,916 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-14 4:28 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 261,807 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-14 4:28 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 261,807 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-01 5:25 pm |
N/A 2031-06-01 |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
252,500 | $0 | 252,500 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 5:45 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner |
8,104 | $0 | 5,839,411 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 4:32 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director |
8,104 | $0 | 32,225 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 4:32 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director |
8,104 | $0 | 12,993 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 4:32 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director |
8,104 | $0 | 32,225 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 4:31 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
8,104 | $0 | 299,381 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-21 4:31 pm |
N/A 2031-05-20 |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
8,104 | $0 | 6,320,139 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 8:21 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $2.3 | 271,807 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-13 8:21 pm |
N/A 2029-04-22 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 271,807 (Direct) |
View |